Systems Biology of Amyotrophic Lateral Sclerosis (ALS)

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07007390

Enrollment

Registered

2025-06-05

Start date

2025-06-01

Completion date

2030-05-01

Last updated

2025-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALS, ALS (Amyotrophic Lateral Sclerosis)

Brief summary

The goal of this observational study is to identify molecular features in multiple clinical samples and/or the patient environment that are associated with ALS. Participants will collect biological samples and answer questionnaires regarding their health at each appointment with their ALS practitioner.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patient of Dr. Espíndola at UFSC

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Molecular features of biological samples that are predictive of ALS progression	We will collect samples and health data from each participant from the time of diagnosis to their death or study termination, whichever comes sooner. Specific time frame: We will collect outcome measures through study completion, an average of 3 years.

Contacts

Primary ContactRaquel Clinical Research Coordinator, BS

studies@viome.com425-368-5248

Backup ContactMomo Chief Science Officer, Head of Clinical Research, PhD

studies@viome.com

Outcome results